Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 15 studies | 28% ± 9% | |
lung | 11 studies | 32% ± 15% | |
intestine | 7 studies | 26% ± 12% | |
kidney | 6 studies | 28% ± 7% | |
liver | 5 studies | 27% ± 18% | |
lymph node | 5 studies | 30% ± 15% | |
eye | 4 studies | 22% ± 7% | |
brain | 4 studies | 25% ± 6% | |
pancreas | 3 studies | 36% ± 1% | |
skin | 3 studies | 17% ± 3% | |
breast | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7229.84 | 1445 / 1445 | 100% | 64.78 | 183 / 183 |
liver | 100% | 7857.10 | 226 / 226 | 100% | 93.80 | 406 / 406 |
ovary | 100% | 5277.45 | 180 / 180 | 100% | 72.32 | 430 / 430 |
skin | 100% | 7779.85 | 1809 / 1809 | 100% | 130.17 | 472 / 472 |
brain | 100% | 6921.26 | 2639 / 2642 | 100% | 103.83 | 705 / 705 |
thymus | 100% | 6079.74 | 653 / 653 | 100% | 103.10 | 604 / 605 |
kidney | 100% | 7140.36 | 89 / 89 | 100% | 97.05 | 899 / 901 |
pancreas | 100% | 2837.59 | 327 / 328 | 100% | 73.98 | 178 / 178 |
uterus | 100% | 5945.02 | 170 / 170 | 100% | 95.33 | 457 / 459 |
intestine | 100% | 6842.87 | 966 / 966 | 99% | 91.75 | 524 / 527 |
stomach | 100% | 5215.36 | 359 / 359 | 99% | 80.93 | 284 / 286 |
prostate | 100% | 6528.56 | 245 / 245 | 99% | 95.21 | 498 / 502 |
adrenal gland | 100% | 7237.79 | 258 / 258 | 99% | 80.66 | 228 / 230 |
breast | 100% | 8352.19 | 459 / 459 | 99% | 80.63 | 1103 / 1118 |
bladder | 100% | 6939.86 | 21 / 21 | 99% | 97.14 | 497 / 504 |
lung | 100% | 6075.42 | 577 / 578 | 99% | 82.14 | 1139 / 1155 |
adipose | 100% | 8930.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 127.18 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 153.20 | 29 / 29 |
muscle | 100% | 5811.53 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7040.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 110.66 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.37 | 1 / 1 |
blood vessel | 100% | 6313.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6269.45 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 4991.31 | 848 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006362 | Biological process | transcription elongation by RNA polymerase I |
GO_0042797 | Biological process | tRNA transcription by RNA polymerase III |
GO_0050821 | Biological process | protein stabilization |
GO_0005736 | Cellular component | RNA polymerase I complex |
GO_0005665 | Cellular component | RNA polymerase II, core complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_1990062 | Cellular component | RPAP3/R2TP/prefoldin-like complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0001055 | Molecular function | RNA polymerase II activity |
GO_0001056 | Molecular function | RNA polymerase III activity |
GO_0001054 | Molecular function | RNA polymerase I activity |
GO_0005515 | Molecular function | protein binding |
GO_0003899 | Molecular function | DNA-directed 5'-3' RNA polymerase activity |
Gene name | POLR2E |
Protein name | Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa, isoform CRA_c (cDNA FLJ55074, highly similar to DNA-directed RNA polymerase II 23 kDa polypeptide) DNA-directed RNA polymerase II subunit E (RPB5 homolog) RNA polymerase II, I and III subunit E DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4) |
Synonyms | hCG_21572 |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase II transcription machinery. Pols are composed of mobile elements that move relative to each other. In Pol II, POLR2E/RPABC1 is part of the lower jaw surrounding the central large cleft and thought to grab the incoming DNA template. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase II transcription machinery. Pols are composed of mobile elements that move relative to each other. In Pol II, POLR2E/RPABC1 is part of the lower jaw surrounding the central large cleft and thought to grab the incoming DNA template. Seems to be the major component in this process. . FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and small RNAs, such as 5S rRNA and tRNAs, respectively. Pol II is the central component of the basal RNA polymerase II transcription machinery. Pols are composed of mobile elements that move relative to each other. In Pol II, POLR2E/RPABC1 is part of the lower jaw surrounding the central large cleft and thought to grab the incoming DNA template. Seems to be the major component in this process. . |
Accessions | ENST00000612655.4 B4DJ89 K7EQN2 ENST00000586746.5 ENST00000589737.5 A0A087WWX0 A0A087WVN5 ENST00000591767.5 K7EJ87 ENST00000585838.2 ENST00000590060.5 ENST00000619917.4 ENST00000215587.11 A0A087WVZ9 ENST00000615234.5 P19388 A0A0A0MQR7 |